hemoperfusion combined with hemodialysis

DEVICE2 trials

Sponsors

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Changhai Hospital

Conditions

End Stage Renal DiseaseEnd-stage Renal Disease

Unknown Phase

The Benefit of Hemodialysis Plus Hemoperfusion on Mortality

CompletedNCT03227770

Xinhua Hospital, Shanghai Jiao Tong University School of MedicineEnd-stage Renal Disease

Start: 2017-12-01End: 2021-12-31Updated: 2022-08-29

Effects of Hemodialysis Plus Hemoperfusion in Maintenance Hemodialysis Patients: A Clinical Study

Active, not recruitingNCT05639010

Changhai HospitalEnd Stage Renal Disease

Start: 2023-01-01End: 2026-12-31Target: 410Updated: 2026-03-23

Related Papers

Hemoadsorption combined with hemodialysis versus hemodialysis alone on mortality in end-stage kidney disease: a randomized, open-label, multicenter trial

Nature Communications2026-03-28

Effects of combined haemodialysis-haemoadsorption therapy in maintenance haemodialysis patients: study protocol for a multicentre, open-label, randomised, parallel controlled trial.

2025-11-12

Randomised, open-label, multicentre trial comparing haemodialysis plus haemoperfusion versus haemodialysis alone in adult patients with end-stage renal disease (HD/HP vs HD): study protocol

BMJ Open2018-07-0112 citations